Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction

Journal of the American College of Cardiology

Volumn 64, Issue 21, 2014, Pages 2281-2293

  Mentz, Robert J ^a   Kelly, Jacob P ^a   Von Lueder, Thomas G ^b   Voors, Adriaan A ^c   Lam, Carolyn S P ^d   Cowie, Martin R ^e   Kjeldsen, Keld ^f   Jankowska, Ewa A ^g   Atar, Dan ^b   Butler, Javed ^h   Fiuzat, Mona ^a   Zannad, Faiez ⁱ   Pitt, Bertram ^j   O'Connor, Christopher M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ROYAL BROMPTON HOSPITAL   (United Kingdom)

^f Mental Health Services CPH   (Denmark)

^g WROCLAW MEDICAL UNIVERSITY   (Poland)

^h EMORY UNIVERSITY   (United States)

ⁱ UNIVERSITÉ DE LORRAINE   (France)

^j UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

more..

Author keywords

comorbidities; ejection fraction; heart failure

Indexed keywords

AGE DISTRIBUTION; ANEMIA; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; COMORBIDITY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HEART MUSCLE FIBROSIS; HUMAN; KIDNEY DYSFUNCTION; OBESITY; OUTCOME ASSESSMENT; PHENOTYPE; SEX DIFFERENCE; SLEEP DISORDERED BREATHING; AGE; ANCESTRY GROUP; ARTHRITIS; HEART STROKE VOLUME; KIDNEY DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; WALKING DIFFICULTY;

AGE FACTORS; ANEMIA; ARTHRITIS; COMORBIDITY; CONTINENTAL POPULATION GROUPS; DIABETES MELLITUS; HEART FAILURE; HUMANS; KIDNEY DISEASES; MOBILITY LIMITATION; OBESITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEX FACTORS; SLEEP APNEA SYNDROMES; STROKE VOLUME;

EID: 84961292073     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.08.036     Document Type: Review

References (124)

1. R.J. Mentz, and G.M. Felker Noncardiac comorbidities and acute heart failure patients Heart Fail Clin 9 2013 359 367 vii
2. C.W. Yancy, M. Lopatin, L.W. Stevenson for the ADHERE Scientific Advisory Committee and Investigators Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database J Am Coll Cardiol 47 2006 76 84
3. Centers for Medicare & Medicaid Services Chronic Conditions Among Medicare Beneficiaries. Chartbook, 2012 Edition 2012 Centers for Medicare & Medicaid Services Baltimore, MD
4. V.M. van Deursen, R. Urso, and C. Laroche Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey Eur J Heart Fail 16 2014 103 111
5. N.M. Hawkins, M.C. Petrie, and P.S. Jhund Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology Eur J Heart Fail 11 2009 130 139
6. R.J. Mentz, M. Fiuzat, and D.M. Wojdyla Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF Eur J Heart Fail 14 2012 395 403
7. C. Ronco, M. Haapio, and A.A. House Cardiorenal syndrome J Am Coll Cardiol 52 2008 1527 1539
8. R.J. Mentz, and E.F. Lewis Epidemiology of cardiorenal syndrome Heart Fail Clin 6 2010 333 346
9. Y.C. Lau, D.A. Lane, and G.Y. Lip Atrial fibrillation and heart failure: a bad combination Am J Cardiol 113 2014 1196 1197
10. G.C. Fonarow, W.G. Stough, W.T. Abraham for the OPTIMIZE-HF Investigators Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry J Am Coll Cardiol 50 2007 768 777
11. B.A. Steinberg, X. Zhao, and P.A. Heidenreich Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes Circulation 126 2012 65 75
12. F. Bursi, S.A. Weston, and M.M. Redfield Systolic and diastolic heart failure in the community JAMA 296 2006 2209 2216
13. T.E. Owan, D.O. Hodge, and R.M. Herges Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259
14. J.G. Cleland, K. Swedberg, and F. Follath The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe: Part 1: patient characteristics and diagnosis Eur Heart J 24 2003 442 463
15. M.S. Nieminen, D. Brutsaert, K. Dickstein for the EuroHeart Survey Investigators; Heart Failure Association, European Society of Cardiology EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population Eur Heart J 27 2006 2725 2736
16. K. Hogg, K. Swedberg, and J. McMurray Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis J Am Coll Cardiol 43 2004 317 327
17. D.S. Lee, P. Gona, and R.S. Vasan Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham Heart Study of the National Heart, Lung, and Blood Institute Circulation 119 2009 3070 3077
18. J.E. Ho, A. Lyass, and D.S. Lee Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction Circ Heart Fail 6 2013 279 286
19. H.M. Krumholz, M. Larson, and D. Levy Sex differences in cardiac adaptation to isolated systolic hypertension Am J Cardiol 72 1993 310 313
20. M. Klapholz, M. Maurer, A.M. Lowe for the New York Heart Failure Consortium Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry J Am Coll Cardiol 43 2004 1432 1438
21. M. Senni, and M.M. Redfield Heart failure with preserved systolic function: a different natural history? J Am Coll Cardiol 38 2001 1277 1282
22. R.S. Bhatia, J.V. Tu, and D.S. Lee Outcome of heart failure with preserved ejection fraction in a population-based study N Engl J Med 355 2006 260 269
23. D.J. van Veldhuisen, G.C. Linssen, and T. Jaarsma B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction J Am Coll Cardiol 61 2013 1498 1506
24. S. Ather, W. Chan, and B. Bozkurt Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction J Am Coll Cardiol 59 2012 998 1005
25. J.B. Braunstein, G.F. Anderson, and G. Gerstenblith Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure J Am Coll Cardiol 42 2003 1226 1233
26. R.T. Campbell, P.S. Jhund, and D. Castagno What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-Preserved, and I-PRESERVE? J Am Coll Cardiol 60 2012 2349 2356
27. S.F. Mohammed, B.A. Borlaug, and V.L. Roger Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study Circ Heart Fail 5 2012 710 719
28. G.M. Felker, L.K. Shaw, and W.G. Stough Anemia in patients with heart failure and preserved systolic function Am Heart J 151 2006 457 462
29. M.R. MacDonald, M.C. Petrie, F. Varyani for the CHARM Investigators Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) programme Eur Heart J 29 2008 1377 1385
30. D.H. Smith, M.L. Thorp, and J.H. Gurwitz Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study Circ Cardiovasc Qual Outcomes 6 2013 333 342
31. W.J. Paulus, and C. Tschöpe A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation J Am Coll Cardiol 62 2013 263 271
32. B.M. Smith, M.R. Prince, and E.A. Hoffman Impaired left ventricular filling in COPD and emphysema: is it the heart or the lungs?: The Multi-Ethnic Study of Atherosclerosis COPD Study Chest 144 2013 1143 1151
33. R.J. Mentz, M. Fiuzat, and M. Kraft Bronchodilators in heart failure patients with COPD: is it time for a clinical trial? J Cardiac Fail 18 2012 413 422
34. L. Caruana, M.C. Petrie, and A.P. Davie Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study BMJ 321 2000 215 218
35. R.J. Mentz, P.H. Schmidt, and M.J. Kwasny The impact of chronic obstructive pulmonary disease in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST Trial J Card Fail 18 2012 515 523
36. R.J. Mentz, P.J. Schulte, and J.L. Fleg Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) Am Heart J 165 2013 193 199
37. N.M. Hawkins, M.C. Petrie, and M.R. Macdonald Heart failure and chronic obstructive pulmonary disease the quandary of beta-blockers and beta-agonists J Am Coll Cardiol 57 2011 2127 2138
38. H.D. Dungen, S. Apostolovic, S. Inkrot for the CIBIS-ELD Investigators and Project Multicentre Trials in the Competence Network Heart Failure Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial Eur J Heart Fail 13 2011 670 680
39. C. Berry, K. Hogg, and J. Norrie Heart failure with preserved left ventricular systolic function: a hospital cohort study Heart 91 2005 907 913
40. C.S. Lam, A. Lyass, and E. Kraigher-Krainer Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community Circulation 124 2011 24 30
41. R.G. Barr, D.A. Bluemke, and F.S. Ahmed Percent emphysema, airflow obstruction, and impaired left ventricular filling N Engl J Med 362 2010 217 227
42. A. Jabbour, P.S. Macdonald, and A.M. Keogh Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial J Am Coll Cardiol 55 2010 1780 1787
43. M. Lainscak, M. Podbregar, and D. Kovacic Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial Respir Med 105 Suppl 1 2011 S44 S49
44. R.J. Mentz, D. Wojdyla, and M. Fiuzat Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF) Am J Cardiol 111 2013 582 587
45. E.M. Hsich, M.V. Grau-Sepulveda, and A.F. Hernandez Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction Am Heart J 163 2012 430 437.e3
46. J.B. Young, W.T. Abraham, and N.M. Albert Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry) Am J Cardiol 101 2008 223 230
47. E. O'Meara, T. Clayton, M.B. McEntegart for the CHARM Committees and Investigators Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program Circulation 113 2006 986 994
48. I.S. Anand Anemia and chronic heart failure: implications and treatment options J Am Coll Cardiol 52 2008 501 511
49. I.S. Anand, Y. Chandrashekhar, and R. Ferrari Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones Br Heart J 70 1993 357 362
50. I.S. Anand, Y. Chandrashekhar, and G.S. Wander Endothelium-derived relaxing factor is important in mediating the high output state in chronic severe anemia J Am Coll Cardiol 25 1995 1402 1407
51. S.D. Katz, R. Rao, and J.W. Berman Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation Circulation 90 1994 12 16
52. J. Lindenfeld Prevalence of anemia and effects on mortality in patients with heart failure Am Heart J 149 2005 391 401
53. H.F. Groenveld, J.L. Januzzi, and K. Damman Anemia and mortality in heart failure patients a systematic review and meta-analysis J Am Coll Cardiol 52 2008 818 827
54. Y.D. Tang, and S.D. Katz The prevalence of anemia in chronic heart failure and its impact on the clinical outcomes Heart Fail Rev 13 2008 387 392
55. P. van der Meer, H.F. Groenveld, and J.L. Januzzi Jr. Erythropoietin treatment in patients with chronic heart failure: a meta-analysis Heart 95 2009 1309 1314
56. I. Anand, J.J. McMurray, and J. Whitmore Anemia and its relationship to clinical outcome in heart failure Circulation 110 2004 149 154
57. D. Scrutinio, A. Passantino, and D. Santoro The cardiorenal anaemia syndrome in systolic heart failure: prevalence, clinical correlates, and long-term survival Eur J Heart Fail 13 2011 61 67
58. S. von Haehling, D.J. van Veldhuisen, and M. Roughton Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study Eur J Heart Fail 13 2011 656 663
59. K. Swedberg, J.B. Young, I.S. Anand for the RED-HF Committees; RED-HF Investigators Treatment of anemia with darbepoetin alfa in systolic heart failure N Engl J Med 368 2013 1210 1219
60. S.D. Anker, J. Comin Colet, G. Filippatos for the FAIR-HF Trial Investigators Ferric carboxymaltose in patients with heart failure and iron deficiency N Engl J Med 361 2009 2436 2448
61. J. Comín-Colet, C. Enjuanes, and G. González Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status Eur J Heart Fail 15 2013 1164 1172
62. I.T. Klip, J. Comin-Colet, and A.A. Voors Iron deficiency in chronic heart failure: an international pooled analysis Am Heart J 165 2013 575 582.e3
63. S. Boudina, and E.D. Abel Diabetic cardiomyopathy revisited Circulation 115 2007 3213 3223
64. A. Aneja, W.H. Tang, and S. Bansilal Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options Am J Med 121 2008 748 757
65. J.E. Liu, V. Palmieri, and M.J. Roman The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study J Am Coll Cardiol 37 2001 1943 1949
66. C.M. Schannwell, M. Schneppenheim, and S. Perings Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy Cardiology 98 2002 33 39
67. L. Amato, G. Paolisso, and F. Cacciatore Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group Diabetes Metab 23 1997 213 218
68. J.W. Swan, S.D. Anker, and C. Walton Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure J Am Coll Cardiol 30 1997 527 532
69. R. Dhingra, and R.S. Vasan Diabetes and the risk of heart failure Heart Fail Clin 8 2012 125 133
70. P. De Groote, N. Lamblin, and F. Mouquet Impact of diabetes mellitus on long-term survival in patients with congestive heart failure Eur Heart J 25 2004 656 662
71. V.P. Harjola, F. Follath, and M.S. Nieminen Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure Eur J Heart Fail 12 2010 239 248
72. J.T. Parissis, P. Rafouli-Stergiou, and A. Mebazaa Acute heart failure in patients with diabetes mellitus: clinical characteristics and predictors of in-hospital mortality Int J Cardiol 157 2012 108 113
73. B.H. Greenberg, W.T. Abraham, and N.M. Albert Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) Am Heart J 154 2007 277.e1 277.e8
74. S. Sarma, R.J. Mentz, M.J. Kwasny for the EVEREST Investigators Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial Eur J Heart Fail 15 2013 194 202
75. M. Komajda, J.J. McMurray, and H. Beck-Nielsen Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial Eur Heart J 31 2010 824 831
76. B.M. Scirica, D.L. Bhatt, E. Braunwald for the SAVOR-TIMI 53 Steering Committee and Investigators Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus N Engl J Med 369 2013 1317 1326
77. D.L. Weir, F.A. McAlister, and A. Senthilselvan Sitagliptin use in patients with diabetes and heart failure: a population-based retrospective cohort study J Am Coll Cardiol HF 2 2014 573 582
78. American Diabetes Association Standards of medical care in diabetes - 2013 Diabetes Care 36 Suppl 1 2013 S11 S66
79. L. van Heerebeek, N. Hamdani, and I. Falcão-Pires Low myocardial protein kinase G activity in heart failure with preserved ejection fraction Circulation 126 2012 830 839
80. B. Waldum, and I. Os The cardiorenal syndrome: what the cardiologist needs to know Cardiology 126 2013 175 186
81. F.P. Brouwers, R.A. de Boer, and P. van der Harst Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND Eur Heart J 34 2013 1424 1431
82. H.L. Hillege, D. Nitsch, M.A. Pfeffer for the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators Renal function as a predictor of outcome in a broad spectrum of patients with heart failure Circulation 113 2006 671 678
83. D.L. Dries, D.V. Exner, and M.J. Domanski The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction J Am Coll Cardiol 35 2000 681 689
84. J.T. Heywood, G.C. Fonarow, M.R. Costanzo for the ADHERE Scientific Advisory Committee and Investigators High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database J Card Fail 13 2007 422 430
85. D. Aronson, and A.J. Burger The relationship between transient and persistent worsening renal function and mortality in patients with acute decompensated heart failure J Card Fail 16 2010 541 547
86. J.M. Testani, J. Chen, and B.D. McCauley Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival Circulation 122 2010 265 272
87. J.E. Blair, P.S. Pang, R.W. Schrier for the EVEREST Investigators Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial Eur Heart J 32 2011 2563 2572
88. C.W. Yancy, M. Jessup, B. Bozkurt for the American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 2013 e147 e239
89. J.J. McMurray, S. Adamopoulos, S.D. Anker for the ESC Committee for Practice Guidelines ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
90. H. Clark, H. Krum, and I. Hopper Worsening renal function during renin-angiotensin-aldosterone system inhibitor initiation and long-term outcomes in patients with left ventricular systolic dysfunction Eur J Heart Fail 16 2014 41 48
91. G.M. Felker, and R.J. Mentz Diuretics and ultrafiltration in acute decompensated heart failure J Am Coll Cardiol 59 2012 2145 2153
92. T. Bitter, L. Faber, and D. Hering Sleep-disordered breathing in heart failure with normal left ventricular ejection fraction Eur J Heart Fail 11 2009 602 608
93. J. Chan, J. Sanderson, and W. Chan Prevalence of sleep-disordered breathing in diastolic heart failure Chest 111 1997 1488 1493
94. T. Kasai, and T.D. Bradley Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications J Am Coll Cardiol 57 2011 119 127
95. T.E. Herrscher, H. Akre, and B. Overland High prevalence of sleep apnea in heart failure outpatients: even in patients with preserved systolic function J Card Fail 17 2011 420 425
96. A. Paulino, T. Damy, and L. Margarit Prevalence of sleep-disordered breathing in a 316-patient French cohort of stable congestive heart failure Arch Cardiovasc Dis 102 2009 169 175
97. D.D. Sin, F. Fitzgerald, and J.D. Parker Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure Am J Respir Crit Care Med 160 1999 1101 1106
98. T.D. Bradley, and J.S. Floras Sleep apnea and heart failure: part I: obstructive sleep apnea Circulation 107 2003 1671 1678
99. K. Ferrier, A. Campbell, and B. Yee Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure Chest 128 2005 2116 2122
100. J.M. Marin, S.J. Carrizo, and E. Vicente Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study Lancet 365 2005 1046 1053
101. N.M. Punjabi, B.S. Caffo, and J.L. Goodwin Sleep-disordered breathing and mortality: a prospective cohort study PLoS Med 6 2009 e1000132
102. A.S. Gami, E.J. Olson, and W.K. Shen Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults J Am Coll Cardiol 62 2013 610 616
103. R. Khayat, W. Abraham, and B. Patt Central sleep apnea is a predictor of cardiac readmission in hospitalized patients with systolic heart failure J Card Fail 18 2012 534 540
104. H. Wang, J.D. Parker, and G.E. Newton Influence of obstructive sleep apnea on mortality in patients with heart failure J Am Coll Cardiol 49 2007 1625 1631
105. S. Javaheri, R. Shukla, and H. Zeigler Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure J Am Coll Cardiol 49 2007 2028 2034
106. D. Yumino, H. Wang, and J.S. Floras Relationship between sleep apnoea and mortality in patients with ischaemic heart failure Heart 95 2009 819 824
107. T. Roebuck, P. Solin, and D.M. Kaye Increased long-term mortality in heart failure due to sleep apnoea is not yet proven Eur Respir J 23 2004 735 740
108. H. Sekizuka, N. Osada, and F. Miyake Sleep disordered breathing in heart failure patients with reduced versus preserved ejection fraction Heart Lung Circ 22 2013 104 109
109. T. Kasai, and T.D. Bradley Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications J Am Coll Cardiol 57 2011 119 127
110. T.D. Bradley, A.G. Logan, R.J. Kimoff for the CANPAP Investigators Continuous positive airway pressure for central sleep apnea and heart failure N Engl J Med 353 2005 2025 2033
111. B.K. Sharma, J.P. Bakker, and D.G. McSharry Adaptive servoventilation for treatment of sleep-disordered breathing in heart failure: a systematic review and meta-analysis Chest 142 2012 1211 1221
112. J.C. Pepperell, N.A. Maskell, and D.R. Jones A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure Am J Respir Crit Care Med 168 2003 1109 1114
113. C.J. Lavie, P.A. McAuley, and T.S. Church Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox J Am Coll Cardiol 63 2014 1345 1354
114. W. Doehner Critical appraisal of the obesity paradox in cardiovascular disease: How to manage patients with overweight in heart failure? Heart Fail Rev 19 2014 637 644
115. K.K. Gaddam, H.O. Ventura, and C.J. Lavie Metabolic syndrome and heart failure - the risk, paradox, and treatment Curr Hypertens Rep 13 2011 142 148
116. M. Haass, D.W. Kitzman, and I.S. Anand Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial Circ Heart Fail 4 2011 324 331
117. J. Afilalo, K.P. Alexander, and M.J. Mack Frailty assessment in the cardiovascular care of older adults J Am Coll Cardiol 63 2014 747 762
118. S.M. McNallan, M. Singh, and A.M. Chamberlain Frailty and healthcare utilization among patients with heart failure in the community J Am Coll Cardiol HF 1 2013 135 141
119. M.M. Rahman, J.A. Kopec, and J. Cibere The relationship between osteoarthritis and cardiovascular disease in a population health survey: a cross-sectional study BMJ Open 3 2013 e002624
120. B.M. Massie, C.M. O'Connor, M. Metra for the PROTECT Investigators and Committees Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure N Engl J Med 363 2010 1419 1428
121. R.J. Mentz, G.M. Felker, and T. Ahmad Learning from recent trials and shaping the future of acute heart failure trials Am Heart J 166 2013 629 635
122. B. Pitt, M.A. Pfeffer, S.F. Assmann for the TOPCAT Investigators Spironolactone for heart failure with preserved ejection fraction N Engl J Med 370 2014 1383 1392
123. L.B. Daniels, and A.S. Maisel Natriuretic peptides J Am Coll Cardiol 50 2007 2357 2368
124. M. Gheorghiade, M. Böhm, S.J. Greene for the ASTRONAUT Investigators and Coordinators Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial JAMA 309 2013 1125 1135